Thoughts on the Role of the Healing Professions and the Events of September 11, 2001
2002; Lippincott Williams & Wilkins; Volume: 105; Issue: 12 Linguagem: Inglês
10.1161/hc1202.105940
ISSN1524-4539
AutoresDonald S. Baim, Thomas J. Brady, S. Ward Casscells, Michael Dunne, Zahi A. Fayad, Valentı́n Fuster, Scott Gazelle, Alan W. Heldman, Thomas S. Hatsukami, Scott Kinlay, Antoine Lafont, Richard Lee, Peter Libby, Bernhard Meier, James E. Muller, M R Naghavi, Christopher O’Donnell, Emerson C. Perin, Mark D. Rekhter, John A. Rumberger, Mary Russell, Robert M. Schwartz, Andrew P. Selwyn, Harald Strauss, Gary J. Tearney, Takanobu Tomaru, E. Muran Tuzcu, Bruce A. Wasserman,
Tópico(s)Social Media in Health Education
ResumoHomeCirculationVol. 105, No. 12Thoughts on the Role of the Healing Professions and the Events of September 11, 2001 Free AccessLetterPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessLetterPDF/EPUBThoughts on the Role of the Healing Professions and the Events of September 11, 2001 Speakers for the Vulnerable Plaque Conference Donald Baim, MD Thomas J. Brady, MD S. Ward Casscells, MD Michael Dunne, MD Zahi Fayad, PhD Valentin Fuster, MD Scott Gazelle, MD MPH, PhD Alan Heldman, MD Thomas Hatsukami, MD Scott Kinlay, MD Antoine Lafont, MD PhD Richard Lee, MD Peter Libby, MD Bernhard Meier, MD James E. Muller, MD Morteza Naghavi, MD Christopher O'Donnell, MD Emerson Perin, MD Mark Rekhter, PhD John Rumberger, MD PhD Mary Russell, MD Robert Schwartz, MD Andrew Selwyn, MD H. William Strauss, MD Gary Tearney, MD PhD Takanobu Tomaru, MD E. Muran Tuzcu, MD Bruce Wasserman, MD Speakers for the Vulnerable Plaque Conference Boston, Mass and on behalf of Donald BaimDonald Baim Boston, Mass Thomas J. BradyThomas J. Brady Boston, Mass S. Ward CasscellsS. Ward Casscells Houston, Tex Michael DunneMichael Dunne Groton, Conn Zahi FayadZahi Fayad New York, NY Valentin FusterValentin Fuster New York, NY, Conference Co-Director Scott GazelleScott Gazelle Boston, Mass Alan HeldmanAlan Heldman Baltimore, Md Thomas HatsukamiThomas Hatsukami Seattle, Wash Scott KinlayScott Kinlay Boston, Mass Antoine LafontAntoine Lafont Paris, France Richard LeeRichard Lee Boston, Mass Peter LibbyPeter Libby Boston, Mass, Conference Co-Director Bernhard MeierBernhard Meier Bern, Switzerland James E. MullerJames E. Muller Boston, Mass, Conference Co-Director Morteza NaghaviMorteza Naghavi Houston, Tex Christopher O'DonnellChristopher O'Donnell Boston, Mass Emerson PerinEmerson Perin Houston, Tex Mark RekhterMark Rekhter Ann Arbor, Mich John RumbergerJohn Rumberger Dublin, Ohio Mary RussellMary Russell Natick, Mass Robert SchwartzRobert Schwartz Rochester, Minn Andrew SelwynAndrew Selwyn Boston, Mass H. William StraussH. William Strauss Stanford, Calif Gary TearneyGary Tearney Boston, Mass Takanobu TomaruTakanobu Tomaru Tokyo, Japan E. Muran TuzcuE. Muran Tuzcu Cleveland, Ohio Bruce WassermanBruce Wasserman Baltimore, Md Originally published26 Mar 2002https://doi.org/10.1161/hc1202.105940Circulation. 2002;105:1509–1510The terrible violence of September 11, a day of mass murder of innocent civilians, had many consequences, some of which directly affected our collective effort to prevent death from vulnerable plaque.Specifically, I refer to the irony that September 11 started as a day to celebrate progress for the vulnerable plaque research community. Over 10 000 individuals congregated at the Transcatheter Cardiovascular Therapeutics (TCT) Conference in Washington, DC. The program included a town meeting on vulnerable plaque, one of those wonderful occasions when the scientists working in isolation come together to share progress and ideas. The event was a rare moment when one could actually feel a massive human problem slowly giving way to organized, dedicated human effort.At 8:00 AM, I gave the opening lecture, which included an overview of the topic of vulnerable and invulnerable plaques.At 8:45, while Dr Peter Fitzgerald described the use of ultrasound and OCT for the diagnosis and treatment of vulnerable plaque, the first plane hit the North Tower.At 9:03, as Dr Mort Naghavi, who is here tonight, reported a novel method for MR imaging of macrophages, the second plane hit the South Tower.At 9:43, as our panel discussion began, the third plane hit the Pentagon, less than 2 miles away.At 10:05, the South Tower collapsed.At 10:10, the hijackers on Flight 93, which was apparently headed for Washington, were foiled by American heroes.At 10:28, the North Tower collapsed, and the death toll for that terrible morning exceeded the chronic daily loss we suffer from heart disease.The TCT, which would have had many valuable discussions of vulnerable plaque and a full review of the extraordinary results of trials of drug eluting stents, was canceled.Many of the 10 000 participants returned to their hotel rooms to follow the tragedy on CNN.I am not pleased by my immediate reaction to the attacks. Although I had spent many years advocating peaceful solutions to world problems, I found myself hoping for a rapid and massive military retaliation. Though prevention of plaque rupture and thrombosis had been an organizing thought for many years, I had trouble seeing heart disease as a significant problem compared with the disaster I was watching. I spent countless hours watching television reports and reading of the breaking news. I struggled to fit this massive and horrible event into the small structures of my life. Even my profession seemed tarnished by the news that the chief lieutenant of Osama bin Laden, Dr Al-Zawahiri, who was the individual in charge of terrorist acts, was a physician.As it did for many others, my recovery began as I learned of the matter-of-fact heroism of the firefighters, police, and rescue workers of New York. It was aided by the courage of a New York emergency room physician who was taking a video at the base of the WTC when it collapsed. The screen went black with the ash and smoke that engulfed him. He said he could not breath and thought that was how he would die. He was surprised as the darkness receded and shadowy figures of firemen and policemen became visible. He walked from one group to another asking if anyone needed a doctor.The health professionals, including a team from Partners Healthcare, stepped in with dedication and expertise, but their effect was limited because the dead far outnumbered the wounded.In the 24 days since the attack, our appreciation of the magnitude of the continuing threat has grown. Concern over attacks with anthrax and smallpox has led to near panic. Chemical warfare has prompted sales of gas masks, and, in a corner of our mind that we try not to visit, we know that a nuclear weapon could level all of Manhattan. The terrorists have demonstrated both the competence and the depravity to make these threats credible.We sense and are told by our government that more attacks are likely. The 21st century triad of weapons of mass destruction, concentrations of individuals in modern skyscrapers, football games, and concerts, and the evil of a small number of individuals presents humanity with a permanent problem.Although we now feel great distress, we are in a better position today than we were on September 10. The world did not become more dangerous on September 11; we became more aware. Yes, there is now more fear in our lives, but we are safer.There are similarities to the problem of vulnerable plaque. On September 10, we were a vulnerable people. The danger was hidden and preventive measures were not applied. The attack occurred and was fatal to 3000, but the nation survived. Our governments now struggle to bring to justice those responsible for the attack. We in the medical profession and in CIMIT, in particular, work to improve methods to cope with additional attacks. Most importantly, because the dead will again outnumber the wounded, we as health professionals must seek ways to prevent future attacks.The startling array of positive forces set in motion by September 11 leaves me with a great pride in our nation, an admiration of the new unity of the civilized world, and a firm belief that humanity will meet this challenge.The positives are numerous and include a dramatic shift from a unilateral to a multilateral world view; a commitment to countering violence with law; renewed appreciation of religion and spirituality; respect for differences within the US, and respect for Islam and the Arab world; intensified efforts to find diplomatic solutions for the Kashmir, Arab-Israeli, and other conflicts; renewed determination to reduce poverty, disease, malnutrition and oppression, conditions that do not justify terrorism, but aid its growth; and the highest level of US and Russian collaboration since World War II, a cooperation CIMIT might aid.As Steven Jay Gould pointed out, humanity is capable of great evil and great good, but the scales are not balanced. The good outweighs the evil by 10 000 to 1, and the good people of the world are mobilized.This mobilization is needed because difficult changes in national behavior will be needed. Prior to September 11, the US refused to sign a comprehensive nuclear test ban treaty, a chemical and biologic weapons treaty, and an authorization for a world criminal court. In each case we refused, in part, because signing would limit our national sovereignty. The 19 terrorists violated our sovereignty, and more seek to follow. The balance has now been tipped from pride in national autonomy to the benefits of a global community ruled by international law. As health professionals dedicated to preserving life, advocacy of these changes and strengthening of our medical ties with colleagues from other cultures are our most effective preventive medicine.On the philosophical level, this destructive violence will lead to greater appreciation of the powerful techniques of nonviolent resistance, which can even be effectively used by governments. The writings of Tolstoy, Thoreau, Paul Dudley White, and Gandhi hold wisdom for our future. With satyagraha, Gandhi taught of the force born of images of truth and love. The image of the murderers is of a plane colliding with innocent victims; the image of our response is of an Afghan carrying a bag of American wheat.September 11 belonged to the terrorists. The following 25 days, tonight, and the future, belong to the positive forces of the world, our nation, and our healing profession. The satirical newspaper the Onion flashed the headline "Hijackers Surprised to Find Selves in Hell." Osama bin Laden and Al-Zawahiri (I won't call him doctor) are presumably in a cave in Afghanistan, with commandos closing in to bring them to justice. We find ourselves in a world of promise.The vulnerable plaque research community, a dedicated group so abruptly and sadly scattered on the day of evil, reconvenes in solidarity and celebration. Let us strengthen ties with our colleagues, plan new collaborations, and, as is within our power, hasten the day that disasters from cardiovascular disease, will no longer occur.Thank you.Footnotes Previous Back to top Next FiguresReferencesRelatedDetailsCited By Ashikaga T (2018) Excimer Laser Coronary Atherectomy Textbook of Catheter-Based Cardiovascular Interventions, 10.1007/978-3-319-55994-0_43, (699-712), . Ashikaga T and Komiyama K (2016) Pretreatment of Excimer Laser Atherectomy for the Saphenous Vein Graft Coronary Graft Failure, 10.1007/978-3-319-26515-5_55, (637-642), . Maruyama Y and Ochi M (2016) Redo Operation Off-Pump Coronary Artery Bypass, 10.1007/978-4-431-54986-4_21, (163-174), . Vermeersch P and Schoors D (2016) Percutaneous Coronary Intervention of Saphenous Vein Graft Failure Coronary Graft Failure, 10.1007/978-3-319-26515-5_51, (595-602), . Wu C, Hwang J and Lin J (2016) Percutaneous Coronary Intervention Strategy of Coronary Bypass Graft Failure Coronary Graft Failure, 10.1007/978-3-319-26515-5_62, (683-688), . Maak T and Wylie J (2016) Medical Device Regulation, Journal of the American Academy of Orthopaedic Surgeons, 10.5435/JAAOS-D-15-00403, 24:8, (537-543), Online publication date: 1-Aug-2016. Vermeersch P, Bonnier H and Schoors D (2016) The Use of Protection Devices in Vein Graft Intervention Coronary Graft Failure, 10.1007/978-3-319-26515-5_60, (665-674), . Egron S, Kütting M, Marzelle J, Becquemin J, Schmitz-Rode T and Steinseifer U (2016) What can be done for cerebral embolic protection in TAVI? Analysis in the light of 10 years' experience with protected carotid artery stenting, Expert Review of Medical Devices, 10.1586/17434440.2015.1120666, 13:1, (15-29), Online publication date: 2-Jan-2016. Orbach A, Strauss B and Jaffe R (2015) Coronary No-Reflow Following Percutaenous Coronary Intervention PanVascular Medicine, 10.1007/978-3-642-37078-6_60, (1865-1884), . Godino C and Colombo A (2015) Complications of Percutaneous Coronary Intervention PanVascular Medicine, 10.1007/978-3-642-37078-6_78, (2297-2322), . Karakyriou M, Hadjimiltiades S, Meditskou S, Nenopoulou E, Efthimiadis G, Vogazianos P, Karvounis C and Styliadis I (2014) Embolization after percutaneous coronary intervention in acute coronary syndromeEmbolusbildung nach perkutaner koronarer Intervention bei akutem Koronarsyndrom, Herz, 10.1007/s00059-014-4184-0, 40:S1, (36-42), Online publication date: 1-Mar-2015. Antoniucci D (2015) Managing Intracoronary Thrombus During PCI Controversies in Cardiology, 10.1007/978-3-319-20415-4_13, (175-185), . Rawlins J, Talwar S and O'Kane P (2015) Optical Coherence Tomography for Assessment of Percutaneous Coronary Intervention with Excimer Laser Coronary Atherectomy Lasers in Cardiovascular Interventions, 10.1007/978-1-4471-5220-0_8, (103-123), . Sarwar B and Brener S (2015) Saphenous Vein Graft Interventions PanVascular Medicine, 10.1007/978-3-642-37078-6_76, (2271-2280), . Crea F, Lanza G and Camici P (2014) Prevention of Iatrogenic CMD Coronary Microvascular Dysfunction, 10.1007/978-88-470-5367-0_11, (241-251), . Sarwar B and Brener S (2014) Saphenous Vein Graft Interventions PanVascular Medicine, 10.1007/978-3-642-37393-0_76-1, (1-12), . Tsukahara R, Tsukahara T and Tigyi G (2013) Regulation of the Nuclear Hormone Receptor Pparγ by Endogenous Lysophosphatidic Acids (LPAS) Lysophospholipid Receptors, 10.1002/9781118531426.ch16, (349-372) Cantrell M, Fry E and Hermiller J (2013) Percutaneous Saphenous Vein Graft and Arterial Graft Intervention Catheter-Based Cardiovascular Interventions, 10.1007/978-3-642-27676-7_32, (575-591), . Weitsman T and Meerkin D (2013) Primary percutaneous coronary intervention: devices to prevent no-reflow phenomenon, Interventional Cardiology, 10.2217/ica.13.28, 5:3, (289-300), Online publication date: 1-Jun-2013. Jujo K, Saito K, Suzuki Y, Amano H, Kawai Y and Takeuchi Y (2013) A case of effective repeated distal protection on acute and subacute phase PCI to occluded sirolimus-eluting stent in SVG, Journal of the Japanese Coronary Association, 10.7793/jcoron.19.498, 19:3, (233-239), . (2012) Current status and procedure of PCI after CABG patients., Journal of the Japanese Coronary Association, 10.7793/jcoron.18.020, 18:2, (171-176), . Porto I, Cautilli G and Camaioni C (2012) Immediate evidence of the benefit of distal protection in vein graft intervention, Journal of Cardiovascular Medicine, 10.2459/JCM.0b013e328347c3aa, 13:12, (828-829), Online publication date: 1-Dec-2012. Douglas J (2012) Percutaneous coronary intervention in patients with prior coronary bypass surgery in 2012, Interventional Cardiology, 10.2217/ica.11.96, 4:1, (111-124), Online publication date: 1-Feb-2012. Kramer D, Xu S and Kesselheim A (2012) Regulation of Medical Devices in the United States and European Union, New England Journal of Medicine, 10.1056/NEJMhle1113918, 366:9, (848-855), Online publication date: 1-Mar-2012. Michishita I (2011) The Final Answer?, Circulation Journal, 10.1253/circj.CJ-10-1262, 75:2, (261-262), . Bateman M, Howard S, Rolfes C, Laske T and Iaizzo P (2011) Cardiac Devices and Testing Springer Handbook of Medical Technology, 10.1007/978-3-540-74658-4_43, (855-876), . Magalhães M and Grube E (2011) A novel approach to aortocoronary saphenous venous graft percutaneous treatment, Interventional Cardiology, 10.2217/ica.11.33, 3:3, (309-313), Online publication date: 1-Jun-2011. Stenberg T, Steigen T and Myrmel T (2011) Microvascular occlusions and coronary microembolization, Scandinavian Cardiovascular Journal, 10.3109/14017431.2011.613202, 45:5, (258-260), Online publication date: 1-Oct-2011. Henry M, Henry I, Polydorou A and Hugel M (2010) Renal angioplasty stenting under embolic protection device: first human study with the FiberNet™ 3D filter, Interventional Cardiology, 10.2217/ica.10.62, 2:5, (651-665), Online publication date: 1-Oct-2010. Rodriguez M, Fischman D and Savage M (2010) Advances in vein graft intervention, Interventional Cardiology, 10.2217/ica.10.66, 2:5, (735-754), Online publication date: 1-Oct-2010. Gick M, Minners J and Neumann F (2010) Primary Angioplasty Clinical Guide to Primary Angioplasty, 10.3109/9781841847351-12, (114-125), Online publication date: 21-May-2010. Migliorini A and Valenti R (2009) Techniques Primary Angioplasty: Mechanical Interventions for Acute Myocardial Infarction, 10.3109/9780203093016.003, (45-66), Online publication date: 1-Jul-2009. Boone R and Sachar R (2009) Vascular Access: Femoral, Radial, Brachial, and Direct Carotid Approach Carotid Artery Stenting: The Basics, 10.1007/978-1-60327-314-5_9, (133-148), . Patel S and Hermiller J (2014) Embolic protection: the FilterWire EZ™ Embolic Protection System, Expert Review of Medical Devices, 10.1586/17434440.5.1.19, 5:1, (19-24), Online publication date: 1-Jan-2008. CARTER L, GOLZAR J, CAVENDISH J and DIXON S (2007) Embolic Protection of Saphenous Vein Graft Percutaneous Interventions, Journal of Interventional Cardiology, 10.1111/j.1540-8183.2007.00284.x, 20:5, (351-358), Online publication date: 1-Oct-2007. Camici P and Crea F (2007) Coronary Microvascular Dysfunction, New England Journal of Medicine, 10.1056/NEJMra061889, 356:8, (830-840), Online publication date: 22-Feb-2007. YOUNG J, COX D, STUCKEY T, BABB J, TURCO M, LANSKY A, MEHRAN R and STONE G (2007) Prospective, Multicenter Study of Thrombectomy in Patients with Acute Myocardial Infarction: The X-Tract AMI Registry, Journal of Interventional Cardiology, 10.1111/j.1540-8183.2007.00223.x, 20:1, (44-50), Online publication date: 1-Feb-2007. van Gaal W and Banning A (2014) Percutaneous coronary intervention and the no-reflow phenomenon, Expert Review of Cardiovascular Therapy, 10.1586/14779072.5.4.715, 5:4, (715-731), Online publication date: 1-Jul-2007. EL-JACK S, SUWATCHAI P, STEWART J, RUYGROK P, ORMISTON J, WEST T and WEBSTER M (2007) Distal Embolization during Native Vessel and Vein Graft Coronary Intervention with a Vascular Protection Device: Predictors of High-Risk Lesions, Journal of Interventional Cardiology, 10.1111/j.1540-8183.2007.00308.x, 20:6, (474-480), Online publication date: 1-Dec-2007. Cardaioli P, Rigatelli G, Arboit M, Giordan M and Roncon L (2007) Treatment of cholesterol crystal embolisation syndrome with filter-assisted stenting, Journal of Cardiovascular Medicine, 10.2459/JCM.0b013e32801452ac, 8:11, (953-955), Online publication date: 1-Nov-2007. MINUTELLO R, BHAGAN S, SHARMA A, SLOTWINER A, FELDMAN D, CUOMO L and WONG S (2007) Long-Term Clinical Benefit of Sirolimus-Eluting Stents Compared to Bare Metal Stents in the Treatment of Saphenous Vein Graft Disease, Journal of Interventional Cardiology, 10.1111/j.1540-8183.2007.00301.x, 20:6, (458-465), Online publication date: 1-Dec-2007. Holmes D (2007) Percutaneous Coronary Intervention for Acute Myocardial Infarction Cardiovascular Medicine, 10.1007/978-1-84628-715-2_47, (1021-1030), . Antoniucci D and Dudek D (2006) How to prevent and manage complications during primary percutaneous cardiovascular interventions Handbook of Complications during Percutaneous Cardiovascular Interventions, 10.3109/9780203090091-19, (181-198), Online publication date: 13-Dec-2006. CHOI S, SALTZMAN A, DABREO A, SALOMON R, GRAY J, SENSENEY-MELLOR H, GOSNELL M and WAXMAN S (2006) Low Power Ultrasound Delivered Through a PTCA-Like Guidewire: Preclinical Feasibility and Safety of a Novel Technology for Intracoronary Thrombolysis, Journal of Interventional Cardiology, 10.1111/j.1540-8183.2006.00110.x, 19:1, (87-92), Online publication date: 1-Feb-2006. Skyschally A, Schulz R, Haude M, Erbel R and Heusch G Coronary Microembolization Myocardial Ischemia, 10.1007/0-387-28658-6_6, (127-144) CRAGUN D and HEUSER R (2006) Embolic Protection Devices in Saphenous Vein Graft Interventions, Journal of Interventional Cardiology, 10.1111/j.1540-8183.2006.00204.x, 19:6, (525-529), Online publication date: 1-Dec-2006. Berger A (2006) Abrupt vessel closure and no-reflow Handbook of Complications during Percutaneous Cardiovascular Interventions, 10.3109/9780203090091-10, (85-101), Online publication date: 13-Dec-2006. HERMILLER J (2006) Bypass Graft Disease: Role of Embolic Protection and Drug-Eluting Stents, Journal of Interventional Cardiology, 10.1111/j.1540-8183.2006.00165.x, 19:s5, (S8-S15), Online publication date: 1-Oct-2006. Liu X and Stone G (2006) Embolic protection devices and complications during percutaneous coronary interventions Handbook of Complications during Percutaneous Cardiovascular Interventions, 10.3109/9780203090091-15, (145-155), Online publication date: 13-Dec-2006. Gumina R and Holmes D (2006) Optimal patient preparation and selection to avoid complications Handbook of Complications during Percutaneous Cardiovascular Interventions, 10.3109/9780203090091-5, (17-37), Online publication date: 13-Dec-2006. Serruys P, Kutryk M and Ong A (2006) Coronary-Artery Stents, New England Journal of Medicine, 10.1056/NEJMra051091, 354:5, (483-495), Online publication date: 2-Feb-2006. CHU W, KUCHULAKANTI P, WANG B, CLAVIJO L, SUDDATH W, PICHARD A, SATLER L, KENT K and WAKSMAN R (2006) Efficacy of Sirolimus-Eluting Stents as Compared to Paclitaxel-Eluting Stents for Saphenous Vein Graft Intervention, Journal of Interventional Cardiology, 10.1111/j.1540-8183.2006.00118.x, 19:2, (121-125), Online publication date: 1-Apr-2006. Cantor W and Newby L (2006) Cardiac Troponin After Revascularization Procedures Cardiovascular Biomarkers, 10.1007/978-1-59745-051-5_7, (103-118), . STONE G (2005) Protecting the Patient from Saphenous Vein Graft Intervention, Journal of Interventional Cardiology, 10.1111/j.1540-8183.2005.4063a.x, 18:2, (77-79), Online publication date: 1-Apr-2005. SHAIA N and HEUSER R (2005) Distal Embolic Protection for SVG Interventions: Can We Afford Not to Use It?, Journal of Interventional Cardiology, 10.1111/j.1540-8183.2005.00089.x, 18:6, (481-484), Online publication date: 1-Dec-2005. Henry M, Henry I, Polydorou A, Rajagopal S, Lakshmi G and Hugel M (2014) Renal angioplasty and stenting: long-term results and the potential role of protection devices, Expert Review of Cardiovascular Therapy, 10.1586/14779072.3.2.321, 3:2, (321-334), Online publication date: 1-Mar-2005. HOFMANN M, STORGER H, SCHWARZ F, SCHWARZ C, REINEMER H, RUEF J, SCHOPF J and HAASE J (2005) Percutaneous Saphenous Vein Graft Interventions with and without Distal Filter Wire Protection, Journal of Interventional Cardiology, 10.1111/j.1540-8183.2005.00088.x, 18:6, (475-479), Online publication date: 1-Dec-2005. DIXON S, MANN J, LAUER M, CASALE P, DIPPEL E, STRUMPF R, FELDMAN R, SHEAR W, RESAR J, ZIMMER S and O'NEILL W (2005) A Randomized, Controlled Trial of Saphenous Vein Graft Intervention with a Filter-Based Distal Embolic Protection Device: TRAP Trial, Journal of Interventional Cardiology, 10.1111/j.1540-8183.2005.00039.x, 18:4, (233-241), Online publication date: 1-Aug-2005. WAHR D and ROGERS C (2005) The Embolic Protection Toolbox, Journal of Interventional Cardiology, 10.1111/j.1540-8183.2005.4063b.x, 18:2, (81-82), Online publication date: 1-Apr-2005. MATTICHAK S, DIXON S, SAFIAN R, HANZEL G, BOURA J and O'NEILL W (2005) Eligibility for Use of Proximal or Distal Embolic Protection Devices During Percutaneous Intervention for Acute Myocardial Infarction, Journal of Interventional Cardiology, 10.1111/j.1540-8183.2005.00040.x, 18:4, (249-254), Online publication date: 1-Aug-2005. VERMEERSCH P and AGOSTONI P (2005) Should Degenerated Saphenous Vein Grafts Routinely Be Sealed with Drug-Eluting Stents?, Journal of Interventional Cardiology, 10.1111/j.1540-8183.2005.00087.x, 18:6, (467-473), Online publication date: 1-Dec-2005. WEBB L, DIXON S, SAFIAN R and O'NEILL W (2005) Usefulness of Embolic Protection Devices During Saphenous Vein Graft Intervention in a Nonselected Population, Journal of Interventional Cardiology, 10.1111/j.1540-8183.2005.04063.x, 18:2, (73-75), Online publication date: 1-Apr-2005. Ho P and Leung C (2004) Rheolytic thrombectomy with distal filter embolic protection as adjunctive therapies to high-risk saphenous vein graft intervention, Catheterization and Cardiovascular Interventions, 10.1002/ccd.10759, 61:2, (202-205), Online publication date: 1-Feb-2004. Zimarino M and De Caterina R (2004) Glycoprotein IIb-IIIa Antagonists in Non-ST Elevation Acute Coronary Syndromes and Percutaneous Interventions: from Pharmacology to Individual Patient's Therapy, Journal of Cardiovascular Pharmacology, 10.1097/00005344-200403000-00001, 43:3, (325-332), Online publication date: 1-Mar-2004. Baim D (2004) New devices for percutaneous coronary intervention are rapidly making bypass surgery obsolete, Current Opinion in Cardiology, 10.1097/01.hco.0000142065.37837.b4, 19:6, (593-597), Online publication date: 1-Nov-2004. Choi J, Gibson C, Murphy S, Davidson C, Kim R and Ricciardi M (2004) Myonecrosis following stent placement: Association between impaired TIMI myocardial perfusion grade and MRI visualization of microinfarction, Catheterization and Cardiovascular Interventions, 10.1002/ccd.20024, 61:4, (472-476), Online publication date: 1-Apr-2004. Porto I, Mitchell A, Ashar V and Banning A (2004) Intravascular ultrasound to guide the management of intracoronary thrombus: a Case Report, Cardiovascular Ultrasound, 10.1186/1476-7120-2-18, 2:1, Online publication date: 1-Oct-2004. Mathew V, Lennon R, Rihal C, Bresnahan J and Holmes D (2004) Applicability of distal protection for aortocoronary vein graft interventions in clinical practice, Catheterization and Cardiovascular Interventions, 10.1002/ccd.20102, 63:2, (148-151), Online publication date: 1-Oct-2004. KOTANI J, NANTO S and NAGATA S (2004) 急性冠症候群治療における今日の問題点 : PCI後の遠位側への塞栓と不完全な再灌流(1. ACSの予防から治療まで)( 第68回日本循環器学会学術集会), Journal of JCS Cardiologists, 10.1253/jjcsc.12.2_199, 12:2, (199-205), Online publication date: 28-Sep-2004. Alexander M and Zaidat O (2004) Future Directions of Endovascular Neurosurgery Modern Neurosurgery, 10.1201/9780203503997.ch12, (209-228), Online publication date: 25-Jun-2004. Grube E, Colombo A, Hauptmann E, Londero H, Reifart N, Gerckens U and Stone G (2003) Initial multicenter experience with a novel distal protection filter during carotid artery stent implantation, Catheterization and Cardiovascular Interventions, 10.1002/ccd.10348, 58:2, (139-146), Online publication date: 1-Feb-2003. Sharma N and Kalaria V (2003) Inadvertent dilation of a saphenous vein graft stenosis by the PercuSurge GuardWire distal protection balloon, Catheterization and Cardiovascular Interventions, 10.1002/ccd.10495, 59:3, (346-349), Online publication date: 1-Jul-2003. Heuser R (2003) Last chance, Catheterization and Cardiovascular Interventions, 10.1002/ccd.10515, 59:3, (350-350), Online publication date: 1-Jul-2003. Matsuo H, Watanabe S, Yasuda S, Hirose T, Iwama M, Tanaka S, Yamaki T, Ono K, Takahashi H, Segawa T, Matsuno Y, Minatoguchi S and Fujiwara H (2003) Myocardial perfusion during transient slow-flow in the patient with old vein graft intervention: Assessment by serial measurement of pressure-derived fractional flow reserve and thermodilution-derived coronary flow reserve, Catheterization and Cardiovascular Interventions, 10.1002/ccd.10659, 60:3, (392-398), Online publication date: 1-Nov-2003. Kornowski R and Assali A (2003) Use of filterwire EX for distal embolic protection during complex percutaneous coronary interventions: Four case studies, Catheterization and Cardiovascular Interventions, 10.1002/ccd.10447, 58:3, (364-369), Online publication date: 1-Mar-2003. Klein L, Kern M, Berger P, Sanborn T, Block P, Babb J, Tommaso C, Hodgson J and Feldman T (2003) Society of cardiac angiography and interventions: Suggested management of the no-reflow phenomenon in the cardiac catheterization laboratory, Catheterization and Cardiovascular Interventions, 10.1002/ccd.10620, 60:2, (194-201), Online publication date: 1-Oct-2003. Huang Z, Katoh O, Nakamura S, Negoro S, Kobayashi T and Tanigawa J (2003) Evaluation of the percusurge guardwire plus temporary occlusion and aspiration system during primary angioplasty in acute myocardial infarction, Catheterization and Cardiovascular Interventions, 10.1002/ccd.10691, 60:4, (443-451), Online publication date: 1-Dec-2003. Gaitonde R, Sharma N, von der Lohe E and Kalaria V (2003) Combined distal embolization protection and rheolytic thrombectomy to facilitate percutaneous revascularization of totally occluded saphenous vein grafts, Catheterization and Cardiovascular Interventions, 10.1002/ccd.10609, 60:2, (212-217), Online publication date: 1-Oct-2003. Londero H (2003) Totally occluded saphenous vein graft recanalization: A dangerous option, Catheterization and Cardiovascular Interventions, 10.1002/ccd.10644, 60:2, (218-220), Online publication date: 1-Oct-2003. SAFIAN R (2002) Saphenous Vein Graft Intervention and Distal Protection: What Are We Protecting?, Journal of Interventional Cardiology, 10.1111/j.1540-8183.2002.tb01111.x, 15:4, (313-314), Online publication date: 1-Aug-2002. Aggarwal A, Terrien E and Terrien C (2002) Treatment of totally occluded saphenous vein grafts using self-expanding stents, Coronary Artery Disease, 10.1097/00019501-200211000-00004, 13:7, (373-376), Online publication date: 1-Nov-2002. Baim D (2002) Epinephrine: A new pharmacologic treatment for no-reflow?, Catheterization and Cardiovascular Interventions, 10.1002/ccd.10320, 57:3, (310-311), Online publication date: 1-Nov-2002. Popma J, Cox N, Hauptmann K, Reifart N, Virmani R, Emira K, Murphy S, Gibson C and Grube E (2002) Initial clinical experience with distal protection using the FilterWire in patients undergoing coronary artery and saphenous vein graft percutaneous intervention, Catheterization and Cardiovascular Interventions, 10.1002/ccd.10313, 57:2, (125-134), Online publication date: 1-Oct-2002. MORALES P and HEUSER R (2002) Guiding Catheter Aspiration to Prevent Embolic Events During Saphenous Vein Graft Intervention, Journal of Interventional Cardiology, 10.1111/j.1540-8183.2002.tb01094.x, 15:6, (491-498), Online publication date: 1-Dec-2002. Werner G, Lang K, Kuehnert H and Figulla H (2002) Intracoronary verapamil for reversal of no-reflow during coronary angioplasty for acute myocardial infarction, Catheterization and Cardiovascular Interventions, 10.1002/ccd.10375, 57:4, (444-451), Online publication date: 1-Dec-2002. MORALES P and HEUSER R (2002) Embolic Protection Devices, Journal of Interventional Cardiology, 10.1111/j.1540-8183.2002.tb01093.x, 15:6, (485-490), Online publication date: 1-Dec-2002. March 26, 2002Vol 105, Issue 12 Advertisement Article InformationMetrics https://doi.org/10.1161/hc1202.105940PMID: 11914263 Originally publishedMarch 26, 2002 PDF download Advertisement
Referência(s)